 Estradiol
"Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
| Descriptor ID |
D004958
|
| MeSH Number(s) |
D04.210.500.365.415.248 D06.472.334.851.437.500
|
| Concept/Terms |
Estradiol- Estradiol
- Estradiol-17 beta
- Estradiol 17 beta
- Estradiol Anhydrous
- Oestradiol
- Estradiol-17beta
- Estradiol 17beta
- 17 beta-Estradiol
- 17 beta Estradiol
- 17 beta-Oestradiol
- 17 beta Oestradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Estradiol".
This graph shows the total number of publications written about "Estradiol" by people in this website by year, and whether "Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 | | 1996 | 3 | 2 | 5 | | 1997 | 3 | 3 | 6 | | 1998 | 2 | 4 | 6 | | 1999 | 0 | 2 | 2 | | 2000 | 4 | 3 | 7 | | 2001 | 4 | 4 | 8 | | 2002 | 6 | 4 | 10 | | 2003 | 9 | 4 | 13 | | 2004 | 2 | 2 | 4 | | 2005 | 5 | 5 | 10 | | 2006 | 5 | 7 | 12 | | 2007 | 9 | 8 | 17 | | 2008 | 7 | 11 | 18 | | 2009 | 4 | 8 | 12 | | 2010 | 10 | 6 | 16 | | 2011 | 5 | 8 | 13 | | 2012 | 6 | 9 | 15 | | 2013 | 7 | 6 | 13 | | 2014 | 5 | 7 | 12 | | 2015 | 8 | 7 | 15 | | 2016 | 7 | 3 | 10 | | 2017 | 6 | 7 | 13 | | 2018 | 6 | 7 | 13 | | 2019 | 5 | 5 | 10 | | 2020 | 5 | 7 | 12 | | 2021 | 5 | 5 | 10 | | 2022 | 0 | 7 | 7 | | 2023 | 1 | 9 | 10 | | 2024 | 4 | 2 | 6 | | 2025 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Estradiol" by people in Profiles.
-
Hiransuthikul A, Thammajaruk N, Kerr S, Janamnuaysook R, Nonenoy S, Hongchookiat P, Trichavaroj R, Tawon Y, Boonruang J, Teeratakulpisarn N, Cressey TR, Anderson PL, Phanuphak N. No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study. J Int AIDS Soc. 2025 May; 28(5):e26502.
-
van Eeghen SA, Pyle L, Narongkiatikhun P, Choi YJ, Obeid W, Parikh CR, Vosters TG, van Valkengoed IG, Krebber MM, Touw DJ, den Heijer M, Bjornstad P, van Raalte DH, Nokoff NJ. Unveiling mechanisms underlying kidney function changes during sex hormone therapy. J Clin Invest. 2025 May 01; 135(9).
-
Santoro N, Neal-Perry G, Stute P, Blogg M, Mancuso S, Morga A, Ottery FD, Siddiqui E. Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy. Curr Med Res Opin. 2025 Feb; 41(2):375-384.
-
Scholl JL, Rogers JT, Feng N, Forster GL, Watt MJ, Yaeger JDW, Buchanan MW, Lowry CA, Renner KJ. Corticosterone rapidly modulates dorsomedial hypothalamus serotonin and behavior in an estrogen- and progesterone-dependent manner in adult female rats: potential role of organic cation transporter 3 (OCT3). Stress. 2025 Dec; 28(1):2457765.
-
Levy MV, Fandl HK, Hijmans JG, Stockelman KA, Ruzzene ST, Reiakvam WR, Goldthwaite ZA, Greiner JJ, DeSouza CA, Garcia VP. Effect of 17?-Estradiol on Endothelial Cell Expression of Inflammation- Related MicroRNA. Microrna. 2025; 14(1):3-8.
-
Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
-
Wenner MM, Shenouda N, Shoemaker L, Kuczmarski A, Haigh K, Del Vecchio A, Schwab A, McGinty SJ, Edwards DG, Pohlig RT, Nuckols VR, DuBose L, Moreau KL. Characterizing vascular and hormonal changes in women across the life span: a cross-sectional analysis. Am J Physiol Heart Circ Physiol. 2024 Nov 01; 327(5):H1286-H1295.
-
Popp KL, Bozzini BN, Reynoso M, Coulombe J, Guerriere KI, Proctor SP, Castellani CM, Walker LA, Zurinaga N, Kuhn K, Foulis SA, Bouxsein ML, Hughes JM, Santoro N. Hypothalamic-pituitary-ovarian axis suppression is common among women during US Army Basic Combat Training. Br J Sports Med. 2024 Sep 09; 58(18):1052-1060.
-
Rothman MS, Ariel D, Kelley C, Hamnvik OR, Abramowitz J, Irwig MS, Soe K, Davidge-Pitts C, Misakian AL, Safer JD, Iwamoto SJ. The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels. Endocr Pract. 2024 Sep; 30(9):870-878.
-
Lersten IL, Grau L, Jahandideh S, Devine K, Zalles L, Plosker SM, Imudia AN, Hoyos LR, Uhler ML, Homer M, Roeca C, Sammel MD, Polotsky AJ. High estradiol levels in fresh embryo transfer cycles are not associated with detrimental impact on birth outcomes. J Assist Reprod Genet. 2024 Apr; 41(4):893-902.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|